All News

Asia-Pacific Region is anticipated to capture over one-third market share for Oncology Biosimilars , expanding at a CAGR of 30.7% across the forecast period 2020-2025

The demand for oncology biosimilar drugs has augmented in recent years. This is attributed to the rising prevalence of various types of cancers across the world. In addition, existing anti-cancer drugs in the pipeline are quite expensive, thus rendering them unaffordable to people in lower and middle income countries. As a consequence, the market for biosimilars has burgeoned.

Click HERE To Get A SAMPLE (Including Full TOC, Table & Figures) At-

global oncolology biosimilars market size growth forecast by disease indication

However, the current COVID-19 pandemic is poised to stall growth trajectory of the market, owing to supply chain disruptions from leading biosimilar manufacturing hubs and shifting priorities of healthcare providers. These shifting priorities are delaying clinical trials for biosimilars, thus delaying their adoption. However, long-term prospects are highly optimistic, with the industry registering an aggrandizing CAGR of 29.4% by 2025-end.

Key Takeaways of Oncology Biosimilars Market Study:

  • By drug class, the granulocyte-colony stimulating factor (G-CSF) category shall dominate the oncology biosimilars market, capturing more than 3/5th of the total market share. Rising adoption of chemotherapy is the key growth driver of the segment. However, monoclonal antibodies are set to grow the fastest, expanding 4.0x, attributed to modification of manufacturing facilities to develop complex and effective drugs.

Need More Information About Report Methodology? Click Here-

  • By disease indication, the blood cancer and neutropenia segments are set to account for the majority of the market share, accounting for 22.3% and 54.7% respectively. Rising FDA approvals for biosimilar products manufactured by leading market players are attributed as key drivers behind the expansion. Examples of such drugs are filgrastim-sndz and filgrastim-aafi.
  • By end-user, hospital pharmacies shall expand the fastest, at a whopping CAGR of 29.5%. The growing trend of physicians prescribing biosimilars instead of generic drugs is anticipated to heighten market prospects for the segment. More than half of the global oncology biosimilars market is set to be captured by the hospitals segment.
  • Asia-Pacific dominates the oncology biosimilars market. Financial leverage by virtue of collaborations between leading giants is a key growth driver. The region is anticipated to capture over one-third market share, expanding at a CAGR of 30.7% across the forecast period. Trailing behind is North America, with a projected market share of 28.4% and a CAGR of 32.0%. New pipeline drugs are attributed as key growth levers.

“The global oncology biosimilar drugs are finding increased application to treat cancer patients, burgeoned by the rapid phasing out of generic and blockbuster drugs. Key players are concentrating on expanding their product pipeline to provide room for manufacturing these drugs,” concludes a Fact.MR analyst.

Global Oncology Biosimilars Market: Competition Structure:

The global oncology biosimilars market consists of the following market players: Celltrion, Inc., Dr. Reddy’s Laboratories Ltd., Biocon, Teva Pharmaceutical Industries Ltd., and Sandoz International GmBh. This makes it a highly consolidated market. Collectively, these market players account for more than 70% of the market share. In order to increase their market footprints, these companies rely heavily on strengthening their product distribution networks through active collaborations.

Biocon, for instance, announced an exclusive global collaboration with Sandoz on next-generation biosimilars in 2018. Likewise, Dr. Reddy’s collaborated with TR Pharm to launch three biosimilars in Turkey in 2016. Other prominent market players in the global oncology biosimilars market include Pfizer, Inc., Celltrion, Inc., Sandoz International GmBh, STADA Arzneimittel AG and Apotex, Inc. to name a few.

Full Access Of This Exclusive Report Is Available At-

Looking for more information?

The research study on the global oncology biosimilars market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the oncology biosimilars market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during the time period. Market statistics have been presented on the basis of drug class (G-CSF, Monoclonal Antibody and Hematopoietic Agents), disease indication (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Neutropenia, Blood Cancer and Others) and distribution channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) across four major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]

All News World

Oncology Biosimilars Market Set to Register Healthy CAGR During 2027

The Oncology Biosimilars Market research report thoroughly explains each and every aspect related to the Global Oncology Biosimilars Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business.

Oncology Biosimilars Market Insight:

Global oncology biosimilars market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.

Get Free Full PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) at:

This Free report sample includes: 

  • A brief introduction to the research report.
  • Graphical introduction of the regional analysis.
  • Top players in the market with their revenue analysis.
  • Selected illustrations of market insights and trends.
  • Example pages from the report.

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

Prominent Key Players – Covered in the report: 

Amgen Inc, Pfizer Inc, Eli Lilly and Company, Novartis AG, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd, Allergan, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Endo International plc, Sun Pharmaceutical Industries Ltd, Mylan N.V., Apotex Inc, Biocad, and others.

Key Pointers Covered in the Oncology Biosimilars Market Industry Trends and Forecast 

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Regulatory Framework and Changes
  • Prices and Reimbursement Analysis
  • Market Shares in different regions
  • Recent Developments for Market Competitors
  • Market upcoming applications
  • Market innovators study

The Oncology Biosimilars market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Oncology Biosimilars market.

Major Regions as Follows: 

  • North America(USA, Canada and Mexico)
  • Europe(Germany, France, UK, Russia and Italy)
  • Asia-Pacific(China, Japan, Korea, India and Southeast Asia)
  • South America(Brazil, Argentina, Columbia etc.)
  • Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Get Table Of Contents of This Premium Research For Free @

The report includes accurately drawn facts and figures, along with graphical representations of vital market data. The research report sheds light on the emerging market segments and significant factors influencing the growth of the industry to help investors capitalize on the existing growth opportunities.

How insights and forecast from the reports could benefit you:

  • The 360-degree Oncology Biosimilars overview based on a global and regional level
  • Market Share & Sales Revenue by Key Players & Emerging Regional Players
  • A separate chapter on Market Entropy to gain insights on Leaders aggressiveness towards market [Merger & Acquisition / Recent Investment and Key Developments]
  • May vary depending upon the availability and feasibility of data with respect to Industry targeted
  • Patent Analysis** No of patents / Trademark filed in recent years.
  • A complete and useful guide for new market aspirants

Why choose us:

  • We share precise and exact information about the market forecast;
  • Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment;
  • The analysis acknowledges that the sector players key drivers of both conflicts and Oncology Biosimilars growth assess the impact of limitations as well as the opportunities on the sector;
  • Data regarding Oncology Biosimilars industry share by every item fragment, alongside their reasonable worth, have been served in the report;
  • We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players. This will help the company to increase its efficiency;
  • Our report helps readers decipher the current and future constraints of the Oncology Biosimilars market and optimal business strategies to enhance market development;

Table Of Contents: Oncology Biosimilars Market

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers and Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Make an Inquiry of the Oncology Biosimilars Market Report @

To summarize:

The global Oncology Biosimilars market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Customization of the Report:

We are grateful to you for reading our report. If you wish to find more details of the report or want customization, contact us. You can get a detail of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.


US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

[email protected]

Energy Space

Global Oncology Biosimilars Market Size, Share, Growth, Future Scope, Trends 2020-2026

Oncology Biosimilars

“A SWOT Analysis of Oncology Biosimilars, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down.”

The market report, titled “Oncology Biosimilars Market“, is a broad research dependent on Oncology Biosimilars market, which examines the escalated structure of the present market all around the world. Planned by the sufficient orderly system, for example, SWOT investigation, the Oncology Biosimilars market report demonstrates an aggregate appraisal of overall Oncology Biosimilars market alongside the noteworthy players Celltrion Inc., Pfizer Inc., Biocon, BIOCAD, Apotex Inc., Dr. Reddy’s Laboratories Ltd., Sandoz International GmbH, Intas Pharmaceuticals Ltd., STADA Arzneimittel AG, Teva Pharmaceutical Industries Ltd. of the market.

Apply here for the FREE sample copy of the report @:

The conjecture for CAGR (Compound Annual Growth Rate) is expressed by the Oncology Biosimilars Market report in the terms of proportion for the particular time length. This will likewise assist the client with understanding and settle on an exact decision based on an expected diagram. Furthermore, The report presents a detailed segmentation G-CSF, Hematopoietic Agents, Monoclonal Antibodies, Market Trend by Application Retail Pharmacies, Hospital Pharmacies, Online Pharmacies of the global market based on technology, product type, application, and various processes and systems.

Income age and assembling scale are the two superior divisions on which the Oncology Biosimilars market is reliant. An evaluation of the market’s fundamental segment and the geological territories around the globe is additionally canvassed in this report. Different Oncology Biosimilars market factors, for example, development, confinements, and the arranged attributes of each point have been accounted profoundly. Based on this qualities, the Oncology Biosimilars market report predicts the fate of the market all around.

The additional geographical segments are also mentioned in the empirical report.

North America: U.S., Canada, Rest of North America
Europe: UK, Germany, France, Italy, Spain, Rest of Europe
Asia Pacific: China, Japan, India, Southeast Asia, North Korea, South Korea, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East and Africa: GCC Countries, South Africa, Rest of Middle East & Africa

The production and distribution up-scales and downscales along with the market share can enlighten the readers with the overall market growth and development. The entire colossal of fine points scripted in the report provides the entire gist of the report that signifies the market expansion and sales volume or value.

Read Detailed Index of full Research Study at::

This report holds every last part of the global market for this particular area, going from the essential market information to numerous critical criteria, according to which the Oncology Biosimilars market is institutionalized. The principle working areas of the Oncology Biosimilars market are additionally secured dependent on their execution. The Oncology Biosimilars market report covers research of present strategies, directions, and market chain. Considering different variables like merchandise, their chain of generation, chief producers, and supply & order, value, for business is composed in this report.

The report likewise contains as far as possible, attributes of interest and supply, pinpoint examination, and the consecutive introduction of the Oncology Biosimilars market around the world.

Impact Of COVID-19

The most recent report includes extensive coverage of the significant impact of the COVID-19 pandemic on the Heated Jacket division. The coronavirus epidemic is having an enormous impact on the global economic landscape and thus on this special line of business. Therefore, the report offers the reader a clear concept of the current scenario of this line of business and estimates the aftermath of COVID-19.

There are 15 Chapters to display the Global Oncology Biosimilars market

Chapter 1, Definition, Specifications and Classification of Oncology Biosimilars, Applications of Oncology Biosimilars, Market Segment by Regions;
Chapter 2, Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;
Chapter 3, Technical Data and Manufacturing Plants Analysis of Oncology Biosimilars, Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;
Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);
Chapter 5 and 6, Regional Market Analysis that includes United States, China, Europe, Japan, Korea & Taiwan, Oncology Biosimilars Segment Market Analysis (by Type);
Chapter 7 and 8, The Oncology Biosimilars Segment Market Analysis (by Application) Major Manufacturers Analysis of Oncology Biosimilars ;
Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type G-CSF, Hematopoietic Agents, Monoclonal Antibodies, Market Trend by Application Retail Pharmacies, Hospital Pharmacies, Online Pharmacies;
Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;
Chapter 11, The Consumers Analysis of Global Oncology Biosimilars ;
Chapter 12, Oncology Biosimilars Research Findings and Conclusion, Appendix, methodology and data source;
Chapter 13, 14 and 15, Oncology Biosimilars sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Enquire Here Get customization & check discount for report @:

Reasons for Buying Oncology Biosimilars market

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Syndicate Market Research:

At Syndicate Market Research, we provide reports about a range of industries such as healthcare & pharma, automotive, IT, insurance, security, packaging, electronics & semiconductors, medical devices, food & beverage, software & services, manufacturing & construction, defense aerospace, agriculture, consumer goods & retailing, and so on. Every aspect of the market is covered in the report along with its regional data. Syndicate Market Research committed to the requirements of our clients, offering tailored solutions best suitable for strategy development and execution to get substantial results. Above this, we will be available for our clients 24×7.

Ask Queries/Buy Report Directly by Contacting Us @ [email protected]

Contact US:

Syndicate Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Blog: Syndicate Market Research Blog

All News

Global Oncology Biosimilars Market 2020 Trending Vendors – Biocon, Celltrion, Dr Reddy’s Laboratories, F Hoffmann-La Roche

Image result for Oncology BiosimilarsGlobal Oncology Biosimilars Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 is an investigative study of the market that studies changing market scenarios and initial and future assessments. The report discusses all major market aspects including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis. The report is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, market size, market shares, business strategies, top regions, demand, and developments. The report is constructed through a thorough primary and secondary research. With the perspectives of manufacturers, regions, product types, and end industries, the report explains the status and position of worldwide and key regions in this market. The report splits the global Oncology Biosimilars market by product type and applications/end industries

Latest Analysis:

It has a wide-ranging analysis of the impact of key advancements on the market’s future growth, wide-ranging analysis of these extensions on the market’s future growth. This research report covers the market landscape and its progress prospects in the near future during 2020 to 2025 time-period. The report has covered key companies, as well as the new entrants contributing to the growth of the market and companies that are currently adopting new technological trends in the market. It also includes revenue and volume analysis of each region and their respective countries for the forecast years. The growth factors of the market are discussed in detail wherein the different end users of the global Oncology Biosimilars market are explained in detail.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.


The key manufacturers in this market include: Biocon, Celltrion, Dr Reddy’s Laboratories, F Hoffmann-La Roche, Mylan, Sandoz,

By the product type, the market is primarily split into: Breast Cancer, Blood Cancer, Colorectal Cancer, Non-Small, Cell Lung Cancer, Neutropenia, Others

By the end-users/application, this report covers the following segments: Retail Pharmacies, Hospitals

The report contains comprehensive pricing analysis on the basis of product, application, and regional segments. The detailed assessment of the vendor landscape and leading companies has been given to help understand the level of competition in the Oncology Biosimilars market. It provides an exhaustive analysis of various trends of the market to help identify market developments. It further covers the analysis of price, production value market share, and production market share by type. Besides market size by application, this report adds consumption analysis by application.

Market by regional segments, the report lists: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


Reasons For Buying This Report:

  • It offers an analysis of the competitive scenario.
  • It helps in understanding the major key product segments.
  • Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
  • It offers a regional analysis of the market
  • The report highlights most affecting driving and restraining forces in the global Oncology Biosimilars market

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for world’s leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact Us
Mark Stone
Head of Business Development
Phone: +1-201-465-4211
Email: [email protected]